Video Interview: Canaan Partners' Bloch Outlines Funding Priorities
This article was originally published in Scrip
Executive Summary
After raising its 10th fund in 2014, Canaan Partners has been actively investing in early stage US biopharm, medtech and digital health opportunities. Having already committed about a quarter of the fund to six companies, with plans in place to invest in up to another 12 businesses, Dr. Stephen Bloch, a partner at the VC, tells Mike Ward how assets that are ready for commercial development fall into his company's sweet spot.